Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-13 Sale | 2024-11-15 6:52 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $7.545 | $301,800 | 16,005,367 (Indirect Direct) | View |
| 2024-10-02 Sale | 2024-10-04 6:30 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $6.12 | $244,800 | 16,085,367 (Indirect Direct) | View |
| 2024-09-04 Sale | 2024-09-06 4:57 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $6.09 | $243,600 | 16,165,367 (Indirect Direct) | View |
| 2024-08-07 Sale | 2024-08-09 4:56 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 50,000 | $6.86 | $343,000 | 16,271,449 (Indirect Direct) | View |
| 2024-07-10 Sale | 2024-07-12 6:54 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $7.475 | $747,500 | 16,401,449 (Indirect Direct) | View |
| 2024-06-05 Sale | 2024-06-07 4:01 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $8.71 | $871,000 | 10,249,749 (Indirect Direct) | View |
| 2024-05-01 Sale | 2024-05-03 6:24 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $8.1 | $810,000 | 10,400,831 (Indirect Direct) | View |
| 2024-04-03 Sale | 2024-04-05 5:44 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 130,000 | $8.93 | $1,160,900 | 4,077,835 (Indirect Direct) | View |
| 2024-03-28 Sale | 2024-04-01 6:40 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 65,000 | $10.1 | $656,500 | 4,232,835 (Indirect Direct) | View |
| 2024-03-06 Sale | 2024-03-08 7:08 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 61,319 | $11.73 | $719,505 | 10,784,331 (Indirect Direct) | View |
| 2024-02-07 Sale | 2024-02-09 5:34 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 48,272 | $9.2182 | $444,981 | 9,858,536 (Indirect Direct) | View |
| 2024-01-03 Sale | 2024-01-05 8:03 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 55,853 | $9.4994 | $530,567 | 9,916,808 (Indirect Direct) | View |
| 2023-12-06 Sale | 2023-12-08 5:22 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 59,829 | $7.4946 | $448,394 | 9,982,661 (Indirect Direct) | View |
| 2023-11-01 Sale | 2023-11-03 6:14 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 62,177 | $5.1675 | $321,301 | 10,079,403 (Indirect Direct) | View |
| 2023-10-04 Sale | 2023-10-06 6:12 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 59,794 | $7.2085 | $431,025 | 10,141,580 (Indirect Direct) | View |
| 2023-09-06 Sale | 2023-09-08 5:01 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 58,765 | $8.8053 | $517,442 | 10,211,374 (Indirect Direct) | View |
| 2023-08-02 Sale | 2023-08-04 5:51 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 65,015 | $13.04 | $847,712 | 10,297,052 (Indirect Direct) | View |
| 2023-07-12 Sale | 2023-07-14 6:52 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 56,818 | $12.54 | $712,242 | 10,372,067 (Indirect Direct) | View |
| 2023-06-07 Sale | 2023-06-09 5:12 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 56,436 | $9.0511 | $510,808 | 10,438,885 (Indirect Direct) | View |
| 2023-05-03 Sale | 2023-05-05 6:44 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 58,073 | $4.7928 | $278,335 | 30,174,484 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-15 Tax Withholding | 2024-11-19 6:26 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 26,023 | $6.175 | 9,902,644 (Direct) | View |
| 2024-11-13 Conversion | 2024-11-15 6:52 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $0 | 16,005,367 (Direct) | View |
| 2024-10-02 Conversion | 2024-10-04 6:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $0 | 16,085,367 (Direct) | View |
| 2024-09-04 Conversion | 2024-09-06 4:57 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $0 | 16,165,367 (Direct) | View |
| 2024-08-30 Exercise | 2024-08-30 4:26 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $0 | 10,048,667 (Direct) | View |
| 2024-08-30 Exercise | 2024-08-30 4:26 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $2.48 | 10,048,667 (Direct) | View |
| 2024-08-29 Exercise | 2024-08-29 4:22 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $0 | 10,048,667 (Direct) | View |
| 2024-08-29 Exercise | 2024-08-29 4:22 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $2.48 | 10,048,667 (Direct) | View |
| 2024-08-28 Exercise | 2024-08-28 4:12 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $0 | 10,048,667 (Direct) | View |
| 2024-08-28 Exercise | 2024-08-28 4:12 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $2.48 | 10,048,667 (Direct) | View |
| 2024-08-27 Exercise | 2024-08-27 4:10 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $0 | 10,048,667 (Direct) | View |
| 2024-08-27 Exercise | 2024-08-27 4:10 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $2.48 | 10,048,667 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-26 4:42 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $0 | 10,048,667 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-26 4:42 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $2.48 | 10,048,667 (Direct) | View |
| 2024-08-23 Exercise | 2024-08-23 5:25 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $0 | 10,048,667 (Direct) | View |
| 2024-08-23 Exercise | 2024-08-23 5:25 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $2.48 | 10,048,667 (Direct) | View |
| 2024-08-15 Tax Withholding | 2024-08-19 7:09 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 26,082 | $6.69 | 10,048,667 (Direct) | View |
| 2024-08-07 Conversion | 2024-08-09 4:56 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 50,000 | $0 | 16,271,449 (Direct) | View |
| 2024-07-10 Gift | 2024-07-12 6:54 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 16,401,449 (Direct) | View |
| 2024-07-10 Conversion | 2024-07-12 6:54 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $0 | 16,401,449 (Direct) | View |
| 2024-06-05 Conversion(A) | 2024-07-12 6:52 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $0 | 7,235,438 (Direct) | View |
| 2024-06-05 Gift | 2024-06-07 4:01 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 10,249,749 (Direct) | View |
| 2024-06-05 Conversion | 2024-06-07 4:01 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 10,249,749 (Direct) | View |
| 2024-05-15 Tax Withholding | 2024-05-17 7:11 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 26,082 | $10.01 | 10,374,749 (Direct) | View |
| 2024-05-01 Gift | 2024-05-03 6:24 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 10,400,831 (Direct) | View |
| 2024-05-02 Conversion | 2024-05-03 6:24 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 21,296 | $0 | 10,400,831 (Direct) | View |
| 2024-04-03 Gift | 2024-04-05 5:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 4,077,835 (Direct) | View |
| 2024-04-03 Conversion | 2024-04-05 5:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 50,000 | $0 | 4,077,835 (Indirect) | View |
| 2024-03-28 Exercise | 2024-04-01 6:40 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 4,232,835 (Indirect) | View |
| 2024-03-28 Gift | 2024-04-01 6:40 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 4,232,835 (Direct) | View |
| 2024-03-28 Conversion | 2024-04-01 6:40 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 4,232,835 (Indirect) | View |
| 2024-03-06 Exercise | 2024-03-08 7:08 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 39,924 | $0 | 10,784,331 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 7:08 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,784,331 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 7:08 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 8,674 | $11.4 | 10,784,331 (Direct) | View |
| 2024-03-06 Gift | 2024-03-08 7:08 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,784,331 (Direct) | View |
| 2024-03-06 Conversion | 2024-03-08 7:08 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 35,000 | $0 | 10,784,331 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-16 7:57 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 11,148 | $12.43 | 1,104,919 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-13 6:55 pm | N/A 2034-02-09 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 1,011,495 | $0 | 10,866,798 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 6:55 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 3,233 | $10.09 | 10,866,798 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 5:34 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 9,858,536 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 5:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 9,858,536 (Direct) | View |
| 2024-02-07 Gift | 2024-02-09 5:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 9,858,536 (Direct) | View |
| 2024-02-07 Conversion | 2024-02-09 5:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 9,858,536 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-05 8:03 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 9,916,808 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-05 8:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 9,916,808 (Direct) | View |
| 2024-01-03 Gift | 2024-01-05 8:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 9,916,808 (Direct) | View |
| 2024-01-03 Conversion | 2024-01-05 8:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 35,000 | $0 | 9,916,808 (Direct) | View |
| 2023-12-06 Exercise | 2023-12-08 5:22 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 9,982,661 (Direct) | View |
| 2023-12-06 Exercise | 2023-12-08 5:22 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 9,982,661 (Direct) | View |
| 2023-12-06 Gift | 2023-12-08 5:22 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 9,982,661 (Direct) | View |
| 2023-12-06 Conversion | 2023-12-08 5:22 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 9,982,661 (Direct) | View |
| 2023-11-15 Tax Withholding | 2023-11-17 5:50 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 16,913 | $7.18 | 10,052,490 (Direct) | View |
| 2023-11-15 Gift | 2023-11-17 5:50 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,052,490 (Direct) | View |
| 2023-11-15 Conversion | 2023-11-17 5:50 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,052,490 (Direct) | View |
| 2023-11-01 Exercise | 2023-11-03 6:14 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 10,079,403 (Direct) | View |
| 2023-11-01 Exercise | 2023-11-03 6:14 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,079,403 (Direct) | View |
| 2023-11-01 Conversion | 2023-11-03 6:14 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 10,079,403 (Indirect) | View |
| 2023-10-16 Gift | 2023-10-18 5:33 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,131,580 (Direct) | View |
| 2023-10-16 Conversion | 2023-10-18 5:33 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,131,580 (Direct) | View |
| 2023-10-04 Exercise | 2023-10-06 6:12 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 10,141,580 (Direct) | View |
| 2023-10-04 Exercise | 2023-10-06 6:12 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,141,580 (Direct) | View |
| 2023-09-15 Gift | 2023-09-19 5:49 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,201,374 (Direct) | View |
| 2023-09-15 Conversion | 2023-09-19 5:49 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,201,374 (Direct) | View |
| 2023-09-06 Exercise | 2023-09-08 5:01 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 10,211,374 (Direct) | View |
| 2023-09-06 Exercise | 2023-09-08 5:01 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,211,374 (Direct) | View |
| 2023-09-06 Conversion | 2023-09-08 5:01 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 10,211,374 (Indirect) | View |
| 2023-08-15 Tax Withholding | 2023-08-17 6:40 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 16,913 | $9.19 | 873,806 (Direct) | View |
| 2023-08-09 Gift | 2023-08-11 4:59 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,326,976 (Direct) | View |
| 2023-08-09 Conversion | 2023-08-11 4:59 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,326,976 (Direct) | View |
| 2023-08-02 Exercise | 2023-08-04 5:51 pm | N/A 2032-02-04 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 39,924 | $0 | 10,297,052 (Direct) | View |
| 2023-08-02 Exercise | 2023-08-04 5:51 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,297,052 (Direct) | View |
| 2023-08-02 Exercise | 2023-08-04 5:51 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 8,674 | $11.4 | 10,297,052 (Direct) | View |
| 2023-07-20 Gift | 2023-07-21 5:07 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,362,067 (Direct) | View |
| 2023-07-20 Conversion | 2023-07-21 5:07 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,362,067 (Direct) | View |
| 2023-07-12 Exercise | 2023-07-14 6:52 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 10,372,067 (Direct) | View |
| 2023-07-12 Exercise | 2023-07-14 6:52 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,372,067 (Direct) | View |
| 2023-07-12 Conversion | 2023-07-14 6:52 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 10,372,067 (Indirect) | View |
| 2023-06-15 Gift | 2023-06-16 5:38 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,428,885 (Direct) | View |
| 2023-06-15 Conversion | 2023-06-16 5:38 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,428,885 (Direct) | View |
| 2023-06-07 Exercise | 2023-06-09 5:12 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 10,438,885 (Direct) | View |
| 2023-06-07 Exercise | 2023-06-09 5:12 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,438,885 (Direct) | View |
| 2023-05-15 Tax Withholding | 2023-05-17 6:16 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 11,661 | $5.6 | 941,564 (Direct) | View |
| 2023-05-03 Exercise | 2023-05-05 6:44 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 30,174,484 (Direct) | View |
| 2023-05-03 Exercise | 2023-05-05 6:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 30,174,484 (Direct) | View |
| 2023-01-05 Gift | 2023-05-05 6:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 19,000 | $0 | 30,174,484 (Direct) | View |
| 2023-01-05 Conversion | 2023-05-05 6:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 35,338 | $0 | 30,174,484 (Direct) | View |